Product Code: ETC340809 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The UK pneumonia vaccine market is a crucial segment of the healthcare industry, aimed at preventing pneumococcal infections. Government immunization programs and increased awareness about vaccine-preventable diseases drive this market. Innovations in vaccine development and the introduction of combination vaccines are expected to further bolster market growth.
The UK pneumonia vaccine market growth is propelled by government vaccination programs, rising awareness about preventive healthcare, and advancements in vaccine technology. Increasing incidence of pneumonia also boosts market demand.
Challenges in the UK pneumonia vaccine market include vaccine efficacy against evolving strains, immunization coverage, and public awareness. Addressing global health priorities for pneumonia prevention while ensuring vaccine accessibility, affordability, and distribution equity poses significant challenges. Innovating next-generation vaccines, enhancing cold chain logistics, and strengthening vaccination programs through public-private partnerships are key priorities for market sustainability and disease prevention efforts.
The UK government plays a pivotal role in the pneumonia vaccine market through public health policies and vaccination programs. The National Health Service (NHS) provides free pneumonia vaccines to at-risk populations, including children and the elderly, as part of its immunization schedule. Government policies also support ongoing research and development to improve vaccine efficacy and coverage.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Pneumonia Vaccine Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Pneumonia Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Pneumonia Vaccine Market - Industry Life Cycle |
3.4 United Kingdom (UK) Pneumonia Vaccine Market - Porter's Five Forces |
3.5 United Kingdom (UK) Pneumonia Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 United Kingdom (UK) Pneumonia Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 United Kingdom (UK) Pneumonia Vaccine Market Revenues & Volume Share, By Sector, 2021 & 2031F |
3.8 United Kingdom (UK) Pneumonia Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Kingdom (UK) Pneumonia Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination and preventive healthcare measures |
4.2.2 Rising prevalence of pneumonia cases in the UK |
4.2.3 Government initiatives and campaigns promoting vaccination and immunization programs |
4.3 Market Restraints |
4.3.1 High cost associated with pneumonia vaccines |
4.3.2 Limited accessibility to vaccines in rural or remote areas |
4.3.3 Safety concerns and misconceptions regarding vaccines |
5 United Kingdom (UK) Pneumonia Vaccine Market Trends |
6 United Kingdom (UK) Pneumonia Vaccine Market, By Types |
6.1 United Kingdom (UK) Pneumonia Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Pneumonia Vaccine Market Revenues & Volume, By Vaccine Type, 2021-2031F |
6.1.3 United Kingdom (UK) Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2021-2031F |
6.1.4 United Kingdom (UK) Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2021-2031F |
6.2 United Kingdom (UK) Pneumonia Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Pneumonia Vaccine Market Revenues & Volume, By Prevnar 13, 2021-2031F |
6.2.3 United Kingdom (UK) Pneumonia Vaccine Market Revenues & Volume, By Synflorix, 2021-2031F |
6.2.4 United Kingdom (UK) Pneumonia Vaccine Market Revenues & Volume, By Pneumovax 23, 2021-2031F |
6.3 United Kingdom (UK) Pneumonia Vaccine Market, By Sector |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Pneumonia Vaccine Market Revenues & Volume, By Public, 2021-2031F |
6.3.3 United Kingdom (UK) Pneumonia Vaccine Market Revenues & Volume, By Private, 2021-2031F |
6.4 United Kingdom (UK) Pneumonia Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Pneumonia Vaccine Market Revenues & Volume, By Distribution Partner Companies, 2021-2031F |
6.4.3 United Kingdom (UK) Pneumonia Vaccine Market Revenues & Volume, By Non-governmental Organizations (NGO), 2021-2031F |
6.4.4 United Kingdom (UK) Pneumonia Vaccine Market Revenues & Volume, By Government Authorities, 2021-2031F |
7 United Kingdom (UK) Pneumonia Vaccine Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Pneumonia Vaccine Market Export to Major Countries |
7.2 United Kingdom (UK) Pneumonia Vaccine Market Imports from Major Countries |
8 United Kingdom (UK) Pneumonia Vaccine Market Key Performance Indicators |
8.1 Vaccination coverage rate among vulnerable populations (e.g., elderly, children) |
8.2 Number of healthcare facilities offering pneumonia vaccination services |
8.3 Percentage of population receiving recommended pneumonia vaccinations |
9 United Kingdom (UK) Pneumonia Vaccine Market - Opportunity Assessment |
9.1 United Kingdom (UK) Pneumonia Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 United Kingdom (UK) Pneumonia Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 United Kingdom (UK) Pneumonia Vaccine Market Opportunity Assessment, By Sector, 2021 & 2031F |
9.4 United Kingdom (UK) Pneumonia Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Kingdom (UK) Pneumonia Vaccine Market - Competitive Landscape |
10.1 United Kingdom (UK) Pneumonia Vaccine Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Pneumonia Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |